Risk Evaluation and Stratification of Low Risk for Cardiovascular Disease in Women

NCT ID: NCT03929341

Last Updated: 2019-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-24

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the ability of Coronary Computed Tomography Angiography (CCTA), used as a first-line diagnostic tool in women with stable chest pain and low risk for Coronary Artery Disease (CAD), to reduce the number of women requiring more than one diagnostic test to rule in or rule out CAD. Half of the participants will undergo CCTA as the first test to investigate stable chest pain, while the other half will undergo any test ordered by their family physician.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronary artery disease (CAD) is the leading cause of death in women globally. Women are more likely to present with atypical chest pain that may be difficult to diagnose using traditional testing methods, resulting in over-investigation.

Coronary computed tomography angiography (CCTA) has high negative predictive value for exclusion of CAD in low to intermediate risk populations. We plan to investigate CCTA as a first line test to exclude coronary artery disease as a cause of stable chest pain and whether it is a cost effective strategy that reduces time to diagnosis, wait times to see cardiologists, emergency department visits, downstream and repeat testing and radiation exposure as compared to usual care with comparable patient safety and satisfaction level.

Another intervention being tested in this trial is the Cardiac Link pathway. This is a new clinical program at Women's College Hospital that aims to expedite cardiology referral for patients exhibiting clinically significant findings while undergoing CCTAs.

We hope that with use of CCTA as the first test, the number of women who require only one test (i.e. CCTA) to sort out whether or not CAD is responsible for their chest pain will increase, thereby decreasing over-investigation of low risk women.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chest Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

angina

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CCTA first approach with Cardiac Link

Patient will undergo Coronary Computed Tomography Angiography as the first test and have Cardiac Link pathway activated for expedited cardiology referral.

Group Type EXPERIMENTAL

Coronary Computed Tomography Angiography (CCTA)

Intervention Type DIAGNOSTIC_TEST

Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.

Cardiac Link

Intervention Type OTHER

Clinical patient flow pathway that will enable radiologist to activate expedited cardiology referral for patients who exhibit clinically significant changes during CCTA.

CCTA first approach without Cardiac Link

Patient will undergo Coronary Computed Tomography Angiography as the first test, but Cardiac Link pathway will not be activated.

Group Type EXPERIMENTAL

Coronary Computed Tomography Angiography (CCTA)

Intervention Type DIAGNOSTIC_TEST

Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.

Usual Care with Cardiac Link

Patient will undergo the usual diagnostic test ordered by their family physician as the first test, and have Cardiac Link pathway activated for expedited cardiology referral.

Group Type ACTIVE_COMPARATOR

Coronary Computed Tomography Angiography (CCTA)

Intervention Type DIAGNOSTIC_TEST

Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.

Cardiac Link

Intervention Type OTHER

Clinical patient flow pathway that will enable radiologist to activate expedited cardiology referral for patients who exhibit clinically significant changes during CCTA.

Usual Care without Cardiac Link

Patient will undergo the usual diagnostic test ordered by their family physician as the first test, but Cardiac Link pathway will not be activated.

Group Type ACTIVE_COMPARATOR

Coronary Computed Tomography Angiography (CCTA)

Intervention Type DIAGNOSTIC_TEST

Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary Computed Tomography Angiography (CCTA)

Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.

Intervention Type DIAGNOSTIC_TEST

Cardiac Link

Clinical patient flow pathway that will enable radiologist to activate expedited cardiology referral for patients who exhibit clinically significant changes during CCTA.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women age ≥ 40 years of age
* Stable chest pain or equivalent symptoms
* Planned non-urgent, non-invasive testing for diagnosis of chest pain or equivalent symptoms

Exclusion Criteria

* Acute coronary syndrome, including acute myocardial infarction or unstable angina, known non-ischemic cardiomyopathy or other cardiac disease (e.g. mitral valve prolapse, etc.) which would require urgent cardiac evaluation
* Known CAD
* Prior cardiac evaluation for current episode of symptoms
* Previously investigated for CAD in the last 12 months
* Severe allergic reaction to iodinated contrast (mild reactions such as urticaria that can be controlled by premedication with Benadryl \& Prednisone may be included in the study)
* Renal failure or dysfunction (estimated Glomerular Filtration Rate\<30ml/min/m2 within the past 3 months)
* Pregnancy (status will be confirmed verbally. For premenopausal patients who are unsure, status will be confirmed by completing a pregnancy strip test).
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Elsie Nguyen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elsie Nguyen

Associate Professor of Radiology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elsie T Nguyen, MD, FRCPC

Role: PRINCIPAL_INVESTIGATOR

Women's College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Women's College Hospital

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fahmeen J Afgani, MBBS

Role: CONTACT

Phone: 1-416-323-6400

Email: [email protected]

Elsie T Nguyen, MD, FRCPC

Role: CONTACT

Phone: 1-416-340-4800

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fahmeen J Afgani, MBBS

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-0069-B

Identifier Type: -

Identifier Source: org_study_id